Point-of-Care Glucose Testing Market Key Players, End User, Demand and Analysis Growth Trends by 2031Posted by Aparna P on August 11th, 2022  Point-of-care testing for glucose monitoring is a valuable tool for managing patients with diabetes in the outpatient settings. Coupling of POCT glucose monitoring devices and electronic medical records enable test results to be shared instantly with care providers.
Some of the key developments in the global point of care glucose testing market are given below:
According to the International Diabetes Federation, an estimated 463 million people had diabetes in 2019, and the number is projected to increase to 578 million by 2030 and 700 million by 2045.
Download a Brochure Of The Latest Research Report
In July 2021, FDA accepted application for Roche’s faricimab for the treatment of neovascular age-related macular degeneration (nAMD) and diabetic macular edema (DME).
In December 2019, Trividia Health and Mellitus Health Partner announced that they have decided to develop diabetes care products and services for pharmacies.
Based on the regional segmentation, the global Point-of-Care Glucose Testing market can be segmented into five key regions. These key regions are North America, Latin America, Asia Pacific, Europe, and the Middle East and Africa.
About TMR Research:
TMR Research is a premier provider of customized market research and consulting services to business entities keen on succeeding in today’s supercharged economic climate. Armed with an experienced, dedicated, and dynamic team of analysts, we are redefining the way our clients’ conduct business by providing them with authoritative and trusted research studies in tune with the latest methodologies and market trends.
Like it? Share it! More by this author |